Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dose of gentamicin in patients with normal renal function and renal impairment.

Literature DB >> 20791473

Dose of gentamicin in patients with normal renal function and renal impairment.

J C Gingell, P M Waterworth.

Abstract

Entities: Chemical Disease Species

Year: 1968 PMID： 20791473 PMCID： PMC1985559 DOI： 10.1136/bmj.2.5596.19

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

× No keyword cloud information.

10 in total

1. GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION.

Authors: R L JAO; G G JACKSON
Journal: JAMA Date: 1964-09-14 Impact factor: 56.272

2. GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.

Authors: J O KLEIN; T C EICKHOFF; M FINLAND
Journal: Am J Med Sci Date: 1964-11 Impact factor: 2.378

3. LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

Authors: R J BULGER; S SIDELL; W M KIRBY
Journal: Ann Intern Med Date: 1963-11 Impact factor: 25.391

4. PRELIMINARY REPORT ON IN VITRO AND CLINICAL STUDIES WITH GENTAMICIN.

Authors: S RABINOVICH; I S SNYDER; I M SMITH
Journal: Antimicrob Agents Chemother (Bethesda) Date: 1963

5. PHARMACOLOGY OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

Authors: J BLACK; B CALESNICK; D WILLIAMS; M J WEINSTEIN
Journal: Antimicrob Agents Chemother (Bethesda) Date: 1963

6. LABORATORY AND CLINICAL STUDIES OF GENTAMICIN.

Authors: D R SWEEDLER; C F GRAVENKEMPER; R J BULGER; J L BRODIE; W M KIRBY
Journal: Antimicrob Agents Chemother (Bethesda) Date: 1963

7. LABORATORY STUDIES ON GENTAMICIN.

Authors: M RUBENIS; V M KOZIJ; G G JACKSON
Journal: Antimicrob Agents Chemother (Bethesda) Date: 1963

8. Correlation between renal function and serum half-life of kanamycin and its application to dosage adjustment.

Authors: A W Sorenen; L Szabo; A Pedersen; A Scharff
Journal: Postgrad Med J Date: 1967-05 Impact factor: 2.401

9. Parenteral administration of gentamicin in renal failure: patients undergoing intermittent haemodialysis.

Authors: J R Curtis; S J McDonald; J H Weston
Journal: Br Med J Date: 1967-05-27

10. Activity of gentamicin against Pseudomonas and hospital Staphylococci.

Authors: M Barber; P M Waterworth
Journal: Br Med J Date: 1966-01-22

10 in total

27 in total

1. Distribution of gentamicin in body fluids.

Authors: G D Chisholm; J S Calnan; P M Waterworth; N D Reis
Journal: Br Med J Date: 1968-04-06

Review 2. Antibacterial Drugs today: II.

Authors: A P Ball; J A Gray; J M Murdoch
Journal: Drugs Date: 1975 Impact factor: 9.546

Dose of gentamicin in patients with normal renal function and renal impairment.

1. GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION.

2. GENTAMICIN: ACTIVITY IN VITRO AND OBSERVATIONS IN 26 PATIENTS.

3. LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

4. PRELIMINARY REPORT ON IN VITRO AND CLINICAL STUDIES WITH GENTAMICIN.

5. PHARMACOLOGY OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

6. LABORATORY AND CLINICAL STUDIES OF GENTAMICIN.

7. LABORATORY STUDIES ON GENTAMICIN.

8. Correlation between renal function and serum half-life of kanamycin and its application to dosage adjustment.

9. Parenteral administration of gentamicin in renal failure: patients undergoing intermittent haemodialysis.

10. Activity of gentamicin against Pseudomonas and hospital Staphylococci.

1. Distribution of gentamicin in body fluids.

Review 2. Antibacterial Drugs today: II.

3. Renal extraction of gentamicin in anesthetized dogs.

4. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.

5. [Indications for the determination of plasma concentrations of aminoglycosides].

6. High-dose melphalan dosage adjustment: possibility of using a test-dose.

Review 7. Clinical pharmacokinetics of aminoglycoside antibiotics.

8. Infection after cadaveric renal transplantation.

9. Significance of Pseudomonas aeruginosa in sputum.

10. Volunteer and clinical studies with carfecillin: a new orally administered ester of carbenicillin.